Last updated: 15 June 2019 at 11:38am EST

Lawrence P. Wennogle Net Worth




The estimated Net Worth of Lawrence P. Wennogle is at least $10.8 Million dollars as of 8 June 2015. Lawrence Wennogle owns over 25,000 units of Intra-Cellular Therapies Inc stock worth over $9,452,080 and over the last 10 years Lawrence sold ITCI stock worth over $1,361,000.

Lawrence Wennogle ITCI stock SEC Form 4 insiders trading

Lawrence has made over 10 trades of the Intra-Cellular Therapies Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Lawrence sold 25,000 units of ITCI stock worth $671,000 on 8 June 2015.

The largest trade Lawrence's ever made was exercising 47,500 units of Intra-Cellular Therapies Inc stock on 19 May 2015 worth over $58,425. On average, Lawrence trades about 13,000 units every 32 days since 2014. As of 8 June 2015 Lawrence still owns at least 126,500 units of Intra-Cellular Therapies Inc stock.

You can see the complete history of Lawrence Wennogle stock trades at the bottom of the page.



What's Lawrence Wennogle's mailing address?

Lawrence's mailing address filed with the SEC is C/O INTRA-CELLULAR THERAPIES, INC., 3960 BROADWAY, NEW YORK, NY, 10032.

Insiders trading at Intra-Cellular Therapies Inc

Over the last 11 years, insiders at Intra-Cellular Therapies Inc have traded over $77,703,646 worth of Intra-Cellular Therapies Inc stock and bought 3,068,522 units worth $52,322,638 . The most active insiders traders include Rory B Riggs, Joel S Marcus, and Christopher D Alafi. On average, Intra-Cellular Therapies Inc executives and independent directors trade stock every 17 days with the average trade being worth of $2,787,280. The most recent stock trade was executed by Sharon Mates on 29 August 2024, trading 70,000 units of ITCI stock currently worth $891,100.



What does Intra-Cellular Therapies Inc do?

intra-cellular therapies is a company based out of 3960 broadway, new york, new york, united states.



What does Intra-Cellular Therapies Inc's logo look like?

Intra-Cellular Therapies Inc logo

Complete history of Lawrence Wennogle stock trades at Intra-Cellular Therapies Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
8 Jun 2015 Lawrence P. Wennogle
Vice President and Drug Discovery
Sale 25,000 $26.84 $671,000
8 Jun 2015
126,500
19 May 2015 Lawrence P. Wennogle
Vice President and Drug Discovery
Option 47,500 $1.23 $58,425
19 May 2015
151,500
16 Oct 2014 Lawrence P. Wennogle
Vice President and Drug Discovery
Sale 5,152 $15.00 $77,280
16 Oct 2014
104,000
13 Oct 2014 Lawrence P. Wennogle
Vice President and Drug Discovery
Sale 3,604 $15.00 $54,060
13 Oct 2014
109,152
8 Oct 2014 Lawrence P. Wennogle
Vice President and Drug Discovery
Sale 4,745 $15.00 $71,175
8 Oct 2014
112,756
3 Oct 2014 Lawrence P. Wennogle
Vice President and Drug Discovery
Sale 16,499 $15.00 $247,485
3 Oct 2014
117,501
15 Sep 2014 Lawrence P. Wennogle
Vice President and Drug Discovery
Sale 5,000 $15.00 $75,000
15 Sep 2014
134,000
21 Jul 2014 Lawrence P. Wennogle
Vice President and Drug Discovery
Option 37,500 $0.50 $18,750
21 Jul 2014
139,000
27 May 2014 Lawrence P. Wennogle
Vice President and Drug Discovery
Sale 5,000 $15.00 $75,000
27 May 2014
101,500
22 May 2014 Lawrence P. Wennogle
Vice President and Drug Discovery
Sale 6,000 $15.00 $90,000
22 May 2014
106,500


Intra-Cellular Therapies Inc executives and stock owners

Intra-Cellular Therapies Inc executives and other stock owners filed with the SEC include: